Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Gürtler LG[au]:

Search results

Items: 1 to 50 of 53

1.

Aspects on the history of transmission and favor of distribution of viruses by iatrogenic action: perhaps an example of a paradigm of the worldwide spread of HIV.

Gürtler LG, Eberle J.

Med Microbiol Immunol. 2017 Aug;206(4):287-293. doi: 10.1007/s00430-017-0505-2. Epub 2017 Apr 22. Review.

2.

Effect of antiretroviral HIV therapy on hepatitis B virus replication and pathogenicity.

Gürtler LG.

Intervirology. 2014;57(3-4):212-7. doi: 10.1159/000360942. Epub 2014 Jul 15.

3.

[Emerging viral diseases in Europe].

Löbermann M, Gürtler LG, Eichler-Löbermann B, Reisinger EC.

Dtsch Med Wochenschr. 2012 Apr;137(17):900-5. doi: 10.1055/s-0032-1304932. Epub 2012 Apr 17. Review. German.

PMID:
22511281
4.

Human immunodeficiency virus type-1 group M quasispecies evolution: diversity and divergence in patients co-infected with active tuberculosis.

Biru T, Lennemann T, Stürmer M, Stephan C, Nisius G, Cinatl J, Staszewski S, Gürtler LG.

Med Microbiol Immunol. 2010 Nov;199(4):323-32. doi: 10.1007/s00430-010-0167-9. Epub 2010 Aug 10.

PMID:
20697741
5.

Near full-length sequence of HIV type 1 subtype J strain 04CMU11421 from Cameroon.

Yamaguchi J, Vallari A, Ngansop C, Makamche F, Ndembi N, Mbanya D, Kaptué L, Gürtler LG, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2010 Jun;26(6):693-7. doi: 10.1089/aid.2009.0305.

PMID:
20518650
6.

Regional spread of HIV-1 M subtype B in middle-aged patients by random env-C2V4 region sequencing.

Stürmer M, Zimmermann K, Fritzsche C, Reisinger E, Doelken G, Berger A, Doerr HW, Eberle J, Gürtler LG.

Med Microbiol Immunol. 2010 May;199(2):123-8. doi: 10.1007/s00430-010-0145-2. Epub 2010 Mar 9.

7.

Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low.

Vallari A, Bodelle P, Ngansop C, Makamche F, Ndembi N, Mbanya D, Kaptué L, Gürtler LG, McArthur CP, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2010 Jan;26(1):109-15. doi: 10.1089/aid.2009.0178.

PMID:
20059396
8.

HIV type 1 group M subtype G in Cameroon: five genome sequences.

Yamaguchi J, Ndembi N, Ngansop C, Mbanya D, Kaptué L, Gürtler LG, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2009 Apr;25(4):469-73. doi: 10.1089/aid.2008.0296.

PMID:
19361281
9.

The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004.

Brennan CA, Bodelle P, Coffey R, Devare SG, Golden A, Hackett J Jr, Harris B, Holzmayer V, Luk KC, Schochetman G, Swanson P, Yamaguchi J, Vallari A, Ndembi N, Ngansop C, Makamche F, Mbanya D, Gürtler LG, Zekeng L, Kaptué L.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):432-9. doi: 10.1097/QAI.0b013e31818a6561.

PMID:
18931623
10.

HIV type 2 intergroup recombinant identified in Cameroon.

Yamaguchi J, Vallari A, Ndembi N, Coffey R, Ngansop C, Mbanya D, Kaptué L, Gürtler LG, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2008 Jan;24(1):86-91. doi: 10.1089/aid.2007.0190.

PMID:
18275352
11.

Identification of HIV type 1 group N infections in a husband and wife in Cameroon: viral genome sequences provide evidence for horizontal transmission.

Yamaguchi J, Coffey R, Vallari A, Ngansop C, Mbanya D, Ndembi N, Kaptué L, Gürtler LG, Bodelle P, Schochetman G, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2006 Jan;22(1):83-92. Erratum in: AIDS Res Hum Retroviruses. 2006 Apr;22(4):373.

PMID:
16438650
12.

No evidence for simian virus 40 DNA sequences in malignant non-Hodgkin lymphomas.

Schüler F, Dölken SC, Hirt C, Dölken MT, Mentel R, Gürtler LG, Dölken G.

Int J Cancer. 2006 Jan 15;118(2):498-504.

13.

Near full-length genomes of 15 HIV type 1 group O isolates.

Yamaguchi J, Bodelle P, Kaptué L, Zekeng L, Gürtler LG, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2003 Nov;19(11):979-88.

PMID:
14678605
14.

Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters.

Yamaguchi J, Vallari AS, Swanson P, Bodelle P, Kaptué L, Ngansop C, Zekeng L, Gürtler LG, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2002 Mar 1;18(4):269-82.

PMID:
11860674
15.

HIV-1 infection transmitted by serum droplets into the eye: a case report.

Eberle J, Habermann J, Gürtler LG.

AIDS. 2000 Jan 28;14(2):206-7. No abstract available.

PMID:
10708294
16.

Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II.

van Binsbergen J, Keur W, Siebelink A, van de Graaf M, Jacobs A, de Rijk D, Nijholt L, Toonen J, Gürtler LG.

J Virol Methods. 1998 Dec;76(1-2):59-71.

PMID:
9923740
17.

Various types of HIV mixed infections in Cameroon.

Takehisa J, Zekeng L, Ido E, Mboudjeka I, Moriyama H, Miura T, Yamashita M, Gürtler LG, Hayami M, Kaptué L.

Virology. 1998 May 25;245(1):1-10.

18.

Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples.

van Binsbergen J, Keur W, vd Graaf M, Siebelink A, Jacobs A, de Rijk D, Toonen J, Zekeng L, Afane Ze E, Gürtler LG.

J Virol Methods. 1997 Dec;69(1-2):29-37.

PMID:
9504748
19.

Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.

Hunt JC, Golden AM, Lund JK, Gürtler LG, Zekeng L, Obiang J, Kaptué L, Hampl H, Vallari A, Devare SG.

AIDS Res Hum Retroviruses. 1997 Aug 10;13(12):995-1005.

PMID:
9264286
20.

Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection.

Eberle J, Loussert-Ajaka I, Brust S, Zekeng L, Hauser PH, Kaptue L, Knapp S, Damond F, Saragosti S, Simon F, Gürtler LG.

J Virol Methods. 1997 Aug;67(1):85-91.

PMID:
9274821
21.

Molecular analyses of HIV-1 group O and HIV-2 variants from Africa.

Hunt JC, Brennan CA, Golden AM, Yamaguchi J, Lund JK, Vallari AS, Hickman RK, Zekeng L, Gürtler LG, Hampl H, Kaptué L, Devare SG.

Leukemia. 1997 Apr;11 Suppl 3:138-41.

PMID:
9209322
22.

Triple HIV-1 infection with group O and Group M of different clades in a single Cameroonian AIDS patient.

Takehisa J, Zekeng L, Miura T, Ido E, Yamashita M, Mboudjeka I, Gürtler LG, Hayami M, Kaptue L.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 1;14(1):81-2. No abstract available.

PMID:
8989217
23.

Evaluation of a new third generation anti-HIV-1/anti-HIV-2 assay with increased sensitivity for HIV-1 group O.

van Binsbergen J, de Rijk D, Peels H, Dries C, Scherders J, Koolen M, Zekeng L, Gürtler LG.

J Virol Methods. 1996 Jul;60(2):131-7.

PMID:
8844618
24.

HIV-1 subtype O: epidemiology, pathogenesis, diagnosis, and perspectives of the evolution of HIV.

Gürtler LG, Zekeng L, Tsague JM, van Brunn A, Afane Ze E, Eberle J, Kaptue L.

Arch Virol Suppl. 1996;11:195-202. Review.

PMID:
8800800
25.

Multicentre study for diagnostic evaluation of an assay for simultaneous detection of antibodies to HIV-1, HIV-2 and HIV-1 subtype 0 (HIV-0).

Bachmann P, Beyer J, Brust S, Engelhardt W, Gürtler LG, Habermehl KO, Karakassopoulos A, Michl U, Mühlbacher A, Stöffler-Meilicke M, et al.

Infection. 1995 Sep-Oct;23(5):322-33.

PMID:
8557399
26.

[Rational substitution with stored blood and blood components].

Krüger KJ, Gürtler LG.

Dtsch Med Wochenschr. 1995 Apr 28;120(17):627-8. German. No abstract available.

PMID:
7736963
27.

Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots.

Gürtler LG, Zekeng L, Simon F, Eberle J, Tsague JM, Kaptue L, Brust S, Knapp S.

J Virol Methods. 1995 Feb;51(2-3):177-83.

PMID:
7537751
28.

Recombinant leech-derived tryptase inhibitor: construction, production, protein chemical characterization and inhibition of HIV-1 replication.

Auerswald EA, Morenweiser R, Sommerhoff CP, Piechottka GP, Eckerskorn C, Gürtler LG, Fritz H.

Biol Chem Hoppe Seyler. 1994 Oct;375(10):695-703.

PMID:
7888082
29.

[Transfusion-associated HIV infection].

Gürtler LG, Eberle J, Bader L.

Infusionsther Transfusionsmed. 1994 Aug;21 Suppl 1:7-10. Review. German.

PMID:
8000258
30.

[HIV infection in ENT: risk of infection and preventive health precautions].

Gürtler LG.

Laryngorhinootologie. 1994 May;73(5):291-3. German.

PMID:
8018247
31.

A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.

Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsague JM, Kaptue L.

J Virol. 1994 Mar;68(3):1581-5.

32.

Haptoglobin (HP), transferrin (TF) and group-specific component (GC) subtype distribution in Bantu-speaking people from Malawi.

Nabulsi A, Emmerich E, Cleve W, Gürtler LG, Cleve H.

Hum Hered. 1993 Sep-Oct;43(5):323-5.

PMID:
8406522
33.

HIV transmission by needle stick and eczematous lesion--three cases from Germany.

Gürtler LG, Eberle J, Bader L.

Infection. 1993 Jan-Feb;21(1):40-1.

PMID:
8449580
34.

[Danger to medical personnel of HIV].

Gürtler LG.

Verh Dtsch Ges Inn Med. 1991;97:391-4. German. No abstract available.

PMID:
1808920
35.

[Current aspects of HIV infection].

Gürtler LG.

Beitr Infusionsther. 1991;28:1-6. Review. German.

PMID:
1725606
36.

Seroprevalence of human parvovirus B19 infection in Sao Tomé and Principe, Malawi and Mascarene Islands.

Schwarz TF, Gürtler LG, Zoulek G, Deinhardt F, Roggendorf M.

Zentralbl Bakteriol. 1989 Jul;271(2):231-6.

PMID:
2550018
38.

Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III.

Gürtler LG, Eberle J, Lorbeer B, Deinhardt F.

J Virol Methods. 1987 Jan;15(1):11-23.

PMID:
3468119
39.

[HTLV-III in persons with intravenous drug abuse. Correlation of antibodies against HTLV-III with neopterin and TH/TS].

Hengster P, Blecha HG, Deinhardt F, Erfle V, Fuchs D, Goebel FD, Gürtler LG, Hausen A, Hinterhuber H, Reibnegger G, et al.

Dtsch Med Wochenschr. 1986 Mar 21;111(12):453-7. German.

PMID:
3004878
40.

Increase in prevalence of anti-HTLV-III in haemophiliacs.

Gürtler LG, Wernicke D, Eberle J, Zoulek G, Deinhardt F, Schramm W.

Lancet. 1984 Dec 1;2(8414):1275-6. No abstract available.

PMID:
6150304
42.

Presence of proteins in human bones 200, 1200 and 1500 years of age.

Gürtler LG, Jäger V, Gruber W, Hillmar I, Schobloch R, Müller PK, Ziegelmayer G.

Hum Biol. 1981 Feb;53(1):137-50. No abstract available.

PMID:
7016716
44.

Ectoenzymes on the surface of cells from human lymphoblastoid lines: 5'-nucleotidase and phosphatase.

Gutensohn W, Gürtler LG, Siegert W, Eichler E, Ernst S.

Blut. 1980 Dec;41(6):411-20.

PMID:
6256029
45.

The lectin binding sites on the membranes of the nuclear envelope, mitochondria and the cell surface of human lymphoblastoid cells.

Gürtler LG, Lefranc SM, Cleve H.

Hoppe Seylers Z Physiol Chem. 1979 Dec;360(12):1829-35.

PMID:
527941
46.

The lectin binding sites on the plasma membrane components of human lymphoblastoid cell lines.

Gürtler LG, Sramota B, Cleve H.

Hoppe Seylers Z Physiol Chem. 1979 Dec;360(12):1819-28.

PMID:
316801
47.
49.
50.

Presence of horse blood group antigens in the major glycoprotein fraction of the erythrocyte membrane.

Gürtler LG, Schmid DO, Yeboa DA, Cleve H.

Anim Blood Groups Biochem Genet. 1978;9(1):41-5.

PMID:
717842

Supplemental Content

Loading ...
Support Center